PRIAX
Price
$27.90
Change
+$0.09 (+0.32%)
Updated
May 8 closing price
Net Assets
2.61B
VEIEX
Price
$29.18
Change
-$0.07 (-0.24%)
Updated
May 8 closing price
Net Assets
112.08B
Ad is loading...

PRIAX vs VEIEX

Header iconPRIAX vs VEIEX Comparison
Open Charts PRIAX vs VEIEXBanner chart's image
Principal Glb Emerging Markets A
Price$27.90
Change+$0.09 (+0.32%)
VolumeN/A
Net Assets2.61B
Vanguard Emerging Mkts Stock Idx I
Price$29.18
Change-$0.07 (-0.24%)
VolumeN/A
Net Assets112.08B
PRIAX vs VEIEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PRIAX vs. VEIEX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRIAX is a Buy and VEIEX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEIEX has more cash in the bank: 112B vs. PRIAX (2.61B). VEIEX pays higher dividends than PRIAX: VEIEX (2.92) vs PRIAX (0.00). PRIAX was incepted earlier than VEIEX: PRIAX (20 years) vs VEIEX (31 years). PRIAX (1.56) is less costly to investors than VEIEX (0.29). PRIAX is a more actively managed with annual turnover of: 28.50 vs. VEIEX (8.00). VEIEX has a lower initial minimum investment than PRIAX: VEIEX (0) vs PRIAX (1000). VEIEX annual gain was more profitable for investors over the last year : 9.04 vs. PRIAX (6.83). VEIEX return over 5 years is better than : 39.11 vs. PRIAX (32.45).
PRIAXVEIEXPRIAX / VEIEX
Total Expense Ratio1.470.29507%
Annual Report Gross Expense Ratio1.560.29538%
Fund Existence20 years31 years-
Gain YTD6.9924.425158%
Front Load6%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.61B112B2%
Annual Yield % from dividends0.002.92-
Returns for 1 year6.839.0476%
Returns for 3 years20.4520.8298%
Returns for 5 years32.4539.1183%
Returns for 10 years18.5224.6475%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SBHIX22.55N/A
N/A
Saratoga Health & Biotechnology I
GCVTX22.40N/A
N/A
Goldman Sachs Large Cp Val Insghts Inv
SVBAX28.19N/A
N/A
JHancock Balanced A
IFPUX20.03N/A
N/A
Independent Franchise Partners US Equity
ARRBX13.25N/A
N/A
Aristotle Small Cap Equity R6